Davis New York Venture Fund returned +17.51% in 2024. The fund has consistently grown wealth for shareholders since its ...

Viatris VTRS, a global healthcare company, is scheduled to report fourth-quarter and full-year 2024 results on Feb. 27, 2025.

The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take ...

NORTHAMPTON, MA / ACCESS Newswire / February 19, 2025 / By: James Headen Pfitzer, Senior Director, Global Policy, Corporate Affairs, Viatris and ... businesses to work together to find a solution ...

Viatris has made a play to expand its branded medicines business by licensing two late-stage drugs from Idorsia – for acute myocardial infarction (AMI) and systemic lupus erythematosus (SLE ...

Leo's pharmaceutical career began unexpectedly when a friend leaving for military service asked him to fill his role at one of Viatris' legacy companies.

We’ve got runaway grooms, cheating scandals, exes being matched together and more! But of course, the most important thing is the success rate. Here’s which Married At First Sight 2025 couples ...

Together, they average 11 years of listed portfolio ... Even so, it's encouraging that the firm showcases strong risk-adjusted performance across its open-end and exchange-traded fund lineup ...

Financials are currently not available. Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.